230-071-5

Applied Filters:

Keyword:'230-071-5'

Showing 1-5 of 5 results for "230-071-5" within Technical Documents

Enhancing the Solubility of Active Pharmaceutical Ingredients Using Hot Melt Extrusion and Polyvinyl Alcohol

assets/sigmaaldrich/product/documents/132/071/polyvinyl-alcohol-wp2488en-mk.pdf https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/132/071/polyvinyl-alcohol-wp2488en-mk.pdf

Brochure: Ascentis® Express Fused-Core® HPLC and UHPLC Columns

Injection: 1.0 µL Detector: UV, 230 nm 0 1 2 3 4 Min 1. Maleic acid 2. Pyrilamine 3. Chlorpheniramine 1 2 3 4 5 6 4.

Apoptosis - Antibodies, Reagents and Kits

) H WB Rb IgG 100 µL 07-875 $309 siRNA plasmid, pKD-PKCδ-v3 H RNAi 5 µg 62-071 $349 siRNA plasmid, pKD-PKCδ-v6 H M R RNAi 5 µg 62-072 $349 PKCε Anti-PKCε H M

Brochure: LC-MS Resource Guide

Temp 25°C Detector UV, 230 nm Injection 5 μL, 1 mg/mL fluoxetine in methanol (Cerilliant®, F-918) Chiral Column Selection Astec® CHIROBIOTIC® CSPs are based on 5, 10 or 16 μm, high purity

Cytoskeletal Signaling Antibodies, Reagents and Kits

WB IH Pur Sh 100 µg AB1685 siRNA siRNA plasmid, pKD-PKCδ-v3 H RNAi 5 µg 62-071 siRNA plasmid, pKD-PKCδ-v6 H M R RNAi 5 µg 62-072 Protein PKCδ, active KA 10 µg 14-504